CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Archigen Biotech Limited

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 1, 2016

Timeline

2010s

Jun 1, 2014
Archigen Biotech Limited— Founded

Drugs by trial phase (1 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

rituximab

Indications

Studied for

Recent trials (2)

NCT02809053Lead sponsorPhase 3Nov 1, 2016
NCT02819726Lead sponsorPhase 1Aug 1, 2016

Details

Founded: Cambridge, GB Jun 1, 2014
Last known activity: Nov 1, 2016